The West Nile Virus Market is estimated at US$794.1 million in 2026 and is projected to grow at a CAGR of 7.3% to reach US$1.39 billion by 2034.
Its value chain includes diagnostic firms, mosquito control suppliers, laboratories, hospitals, public health agencies, research institutions, and blood screening providers. Core applications include diagnostic testing, blood safety screening, mosquito surveillance, public health response, hospital supportive care, and epidemiological monitoring.
This product will be delivered within 1-3 business days.
Market Overview
The West Nile Virus Market covers diagnostic, surveillance, supportive care, vector control, and research activities focused on West Nile virus detection, monitoring, and public health response.Its value chain includes diagnostic firms, mosquito control suppliers, laboratories, hospitals, public health agencies, research institutions, and blood screening providers. Core applications include diagnostic testing, blood safety screening, mosquito surveillance, public health response, hospital supportive care, and epidemiological monitoring.
Key Companies Analysed
- Roche
- Abbott
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Qiagen
- Hologic
- Danaher
- AbbVie
- Pfizer
- GSK
- Bayer
- Takeda
- Quest Diagnostics
- Labcorp
- Grifols
- CSL
- Becton Dickinson
- Merck & Co
- Sanofi
- Eurofins Scientific
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global West Nile Virus Market Overview
3. West Nile Virus Market Dynamics
4. West Nile Virus Market Strategic Analysis
5. Global West Nile Virus Market Size, Share and Forecast, 2025-2034
6. North America West Nile Virus Market Outlook to 2034
7. Europe West Nile Virus Market Outlook to 2034
8. Asia-Pacific West Nile Virus Market Outlook to 2034
9. Middle East and Africa West Nile Virus Market Outlook to 2034
10. South and Central America West Nile Virus Market Outlook to 2034
11. West Nile Virus Market Competitive Landscape
12. Appendix
Companies Mentioned
- Roche
- Abbott
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Qiagen
- Hologic
- Danaher
- AbbVie
- Pfizer
- GSK
- Bayer
- Takeda
- Quest Diagnostics
- Labcorp
- Grifols
- CSL
- Becton Dickinson
- Merck & Co
- Sanofi
- Eurofins Scientific
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 794.1 Million |
| Forecasted Market Value ( USD | $ 1395.3 Million |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
